Skip to main content

letter

. 1988 Apr 23;296(6630):1194–1195. doi: 10.1136/bmj.296.6630.1194-c

The use of varicella vaccine in Britain

H O Kangro, R B Heath

PMCID: PMC2545657 PMID: 2837305

1194

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Andre F. E. Worldwide experience with the Oka-strain live varicella vaccine. Postgrad Med J. 1985;61 (Suppl 4):113–120. [PubMed] [Google Scholar]
Heath R. B., Malpas J. S., Kangro H. O., Ward A., McEniery J. M., Kingston J. E. Efficacy of varicella vaccine in patients with solid tumours. Arch Dis Child. 1987 Jun;62(6):569–572. doi: 10.1136/adc.62.6.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
Lawrence R., Gershon A. A., Holzman R., Steinberg S. P. The risk of zoster after varicella vaccination in children with leukemia. N Engl J Med. 1988 Mar 3;318(9):543–548. doi: 10.1056/NEJM198803033180904. [DOI] [PubMed] [Google Scholar]
Plotkin S. A. Hell's fire and varicella-vaccine safety. N Engl J Med. 1988 Mar 3;318(9):573–575. doi: 10.1056/NEJM198803033180909. [DOI] [PubMed] [Google Scholar]
Preblud S. R., Orenstein W. A., Koplan J. P., Bart K. J., Hinman A. R. A benefit-cost analysis of a childhood varicella vaccination programme. Postgrad Med J. 1985;61 (Suppl 4):17–22. [PubMed] [Google Scholar]
Preblud S. R. Varicella: complications and costs. Pediatrics. 1986 Oct;78(4 Pt 2):728–735. [PubMed] [Google Scholar]
Takahashi M., Hayakawa Y., Shiraki K., Yamanishi K., Asano Y., Ozaki T. Attenuation and laboratory markers of the Oka-strain varicella-zoster virus. Postgrad Med J. 1985;61 (Suppl 4):37–46. [PubMed] [Google Scholar]

ACTIONS

RESOURCES